Status:
COMPLETED
Posterior Capsule Opacification and Optical Quality of Different Hydrophobic Acrylic Intraocular Lenses
Lead Sponsor:
Medical University of Vienna
Conditions:
Posterior Capsule Opacification
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The most frequent long-term complication of cataract surgery remains to be posterior capsule opacification (PCO). During the past decades many new intraocular lenses (IOL) with optimized lens material...
Eligibility Criteria
Inclusion
- Bilateral age-related cataract for which phacoemulsification extraction and posterior IOL implantation has planned
- Age 40 and older
- Visual potential in both eyes of 20/30 or better as determined by investigators estimation
- Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
Exclusion
- Preceding ocular surgery or trauma
- Relevant other ophthalmic diseases (such as pseudoexfoliation, retinal degenerations, etc.)
- Uncontrolled systemic or ocular disease
Key Trial Info
Start Date :
January 27 2012
Trial Type :
INTERVENTIONAL
End Date :
July 7 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03831074
Start Date
January 27 2012
End Date
July 7 2015
Last Update
February 5 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.